Skip to main content
Erschienen in: Supportive Care in Cancer 8/2020

19.12.2019 | Original Article

Hospital Anxiety and Depression Scale (HADS) accuracy in cancer patients

verfasst von: Maria Antonietta Annunziata, Barbara Muzzatti, Ettore Bidoli, Cristiana Flaiban, Francesca Bomben, Marika Piccinin, Katiuscia Maria Gipponi, Giulia Mariutti, Sara Busato, Sara Mella

Erschienen in: Supportive Care in Cancer | Ausgabe 8/2020

Einloggen, um Zugang zu erhalten

Abstract

Purpose

The Hospital Anxiety and Depression Scale (HADS) is a self-report questionnaire designed to screen anxious and depressive states in patients in non-psychiatric settings. In spite of its large use, no agreement exists in literature on HADS accuracy in case finding. The present research addresses the issue of HADS accuracy in cancer patients, comparing its two subscales (HADS-A and HADS-D) against tools not in use in psychiatry, which are able to detect prolonged negative emotional states.

Methods

2121 consecutive adult cancer inpatients were administered the HADS together with the State Anxiety subscale of State-Trait Anxiety Inventory and the Center for Epidemiologic Studies Scale on Depression. Receiver operating characteristic (ROC) curves were computed to identify a cut-off for anxious and depressive states in cancer patients. All indicators were computed together with their corresponding 95% confidence interval (95% CI).

Results

Data of 1628 and 1035 participants were used to assess the accuracy in case finding of HADS-A and HADS-D, respectively. According to the ROC analysis, the optimal cut-off was > 9 units for the HADS-A and > 7 units for the HADS-D. The area under the ROC curve was 0.90 for HADS-A (95% CI 0.88–0.91) and 0.84 for HADS-D (95% CI 0.81–0.86).

Conclusions

This study suggested that risk scores of anxious and depressive states above specific HADS cut-offs are useful in identifying anxious and depressive states in cancer patients, and they may thus be applicable in clinical practice.
Literatur
1.
Zurück zum Zitat Zigmond AS, Snaith RP (1983) The hospital anxiety and depression scale. Acta Psychiatr Scand 67:361–370CrossRef Zigmond AS, Snaith RP (1983) The hospital anxiety and depression scale. Acta Psychiatr Scand 67:361–370CrossRef
2.
Zurück zum Zitat Snaith RP, Zigmond AS (1994) The Hospital Anxiety and Depression Scale manual. Nelson, Windsor, NFER Snaith RP, Zigmond AS (1994) The Hospital Anxiety and Depression Scale manual. Nelson, Windsor, NFER
3.
Zurück zum Zitat Snaith RP (2003) The Hospital Anxiety and Depression Scale. Health Qual Life Outcomes 1:29CrossRef Snaith RP (2003) The Hospital Anxiety and Depression Scale. Health Qual Life Outcomes 1:29CrossRef
4.
Zurück zum Zitat Herrmann C (1997) International experiences with the Hospital Anxiety and Depression Scale. A review of validation data and clinical results. J Psychosom Res 42:17–41CrossRef Herrmann C (1997) International experiences with the Hospital Anxiety and Depression Scale. A review of validation data and clinical results. J Psychosom Res 42:17–41CrossRef
5.
Zurück zum Zitat Bjelland I, Dahl AA, Neckelmann D (2002) The validity of the Hospital Anxiety and Depression Scale: an updated literature review. J Psychosom Res 52:69–77CrossRef Bjelland I, Dahl AA, Neckelmann D (2002) The validity of the Hospital Anxiety and Depression Scale: an updated literature review. J Psychosom Res 52:69–77CrossRef
6.
Zurück zum Zitat Vodermaier A, Linden W, Siu C (2009) Screening for emotional distress in cancer patients: a systematic review of assessment instruments. J Natl Cancer Inst 101(21):1464–1488CrossRef Vodermaier A, Linden W, Siu C (2009) Screening for emotional distress in cancer patients: a systematic review of assessment instruments. J Natl Cancer Inst 101(21):1464–1488CrossRef
7.
Zurück zum Zitat Mitchell AJ, Meader N, Symonds P (2010) Diagnostic validity of the hospital anxiety and depression scale (HADS) in cancer and palliative settings: a metaanalysis. J Affective Disord 126:335–348CrossRef Mitchell AJ, Meader N, Symonds P (2010) Diagnostic validity of the hospital anxiety and depression scale (HADS) in cancer and palliative settings: a metaanalysis. J Affective Disord 126:335–348CrossRef
8.
Zurück zum Zitat Brennan C, Worrall-Davies A, McMillan D, Gilbody S, House A (2010) The hospital anxiety and depression scale: a diagnostic meta-analysis of case-finding ability. J Psychosom Res 69:371–378CrossRef Brennan C, Worrall-Davies A, McMillan D, Gilbody S, House A (2010) The hospital anxiety and depression scale: a diagnostic meta-analysis of case-finding ability. J Psychosom Res 69:371–378CrossRef
9.
Zurück zum Zitat Carey M, Noble N, Sanson-Fisher R, Mackenzie L (2012) Identifying psychological morbidity among people with cancer using the Hospital Anxiety and Depression Scale: time to revisit first principles? Psycho-Oncol. 21:229–238CrossRef Carey M, Noble N, Sanson-Fisher R, Mackenzie L (2012) Identifying psychological morbidity among people with cancer using the Hospital Anxiety and Depression Scale: time to revisit first principles? Psycho-Oncol. 21:229–238CrossRef
10.
Zurück zum Zitat Vodermaier A, Millman RD (2011) Accuracy of the Hospital Anxiety and Depression Scale as a screening tool in cancer patients: a systematic review and meta-analysis. Support Care Cancer 19:1899–1908CrossRef Vodermaier A, Millman RD (2011) Accuracy of the Hospital Anxiety and Depression Scale as a screening tool in cancer patients: a systematic review and meta-analysis. Support Care Cancer 19:1899–1908CrossRef
11.
Zurück zum Zitat Annunziata MA, Muzzatti B, Altoè G (2011) Defining Hospital Anxiety and Depression Scale (HADS) structure by confirmatory factor analysis: a contribution to validation for oncological settings. Ann Oncol 22:2330–2333CrossRef Annunziata MA, Muzzatti B, Altoè G (2011) Defining Hospital Anxiety and Depression Scale (HADS) structure by confirmatory factor analysis: a contribution to validation for oncological settings. Ann Oncol 22:2330–2333CrossRef
12.
Zurück zum Zitat Spielberger CD (1983) State-trait anxiety inventory (form Y). Mind Garden, Palo Alto (CA) Spielberger CD (1983) State-trait anxiety inventory (form Y). Mind Garden, Palo Alto (CA)
13.
Zurück zum Zitat Radloff L (1977) The CES-D Scale: a self-report depression scale for research in the general population. Appl Psych Meas 1:385–401CrossRef Radloff L (1977) The CES-D Scale: a self-report depression scale for research in the general population. Appl Psych Meas 1:385–401CrossRef
14.
Zurück zum Zitat Spielberger CD (1989) S.T.A.I. (State-Trait-Anxiety Inventory). Inventario per l’ansia di stato e di tratto. Forma Y. Organizzazioni Speciali, Firenze Spielberger CD (1989) S.T.A.I. (State-Trait-Anxiety Inventory). Inventario per l’ansia di stato e di tratto. Forma Y. Organizzazioni Speciali, Firenze
15.
Zurück zum Zitat Pedrabissi L, Santinello M (1989) Verifica della validità dello STAI forma Y di Spielberger. BPA. 191:11–14 Pedrabissi L, Santinello M (1989) Verifica della validità dello STAI forma Y di Spielberger. BPA. 191:11–14
16.
Zurück zum Zitat Macor A, Pedrabissi L, Santinello M. (190). Ansia di stato e di tratto: ulteriore contributo alla verifica della validità psicometrica e teorica dello S.T.A.I. forma Y di Spielberger. Psicologia e Società. 15: 67–74 Macor A, Pedrabissi L, Santinello M. (190). Ansia di stato e di tratto: ulteriore contributo alla verifica della validità psicometrica e teorica dello S.T.A.I. forma Y di Spielberger. Psicologia e Società. 15: 67–74
17.
Zurück zum Zitat Pierfederici A, Fava GA, Munari F et al (1982) Validazione italiana del CES-D per la misurazione della depressione. In: Canestrari R (ed) Nuovi metodi in psicoterapia. Organizzazioni Speciali, Firenze, pp 95–103 Pierfederici A, Fava GA, Munari F et al (1982) Validazione italiana del CES-D per la misurazione della depressione. In: Canestrari R (ed) Nuovi metodi in psicoterapia. Organizzazioni Speciali, Firenze, pp 95–103
18.
Zurück zum Zitat Fava GA (1983) Assessing depressive symptoms across cultures: Italian validation of the CES-D self-rating scale. J Clin Psychol 39:249–251CrossRef Fava GA (1983) Assessing depressive symptoms across cultures: Italian validation of the CES-D self-rating scale. J Clin Psychol 39:249–251CrossRef
19.
Zurück zum Zitat Hann D, Winter K, Jacobsen P (1999) Measurement of depressive symptoms in cancer patients: evaluation of the Center for Epidemiological Studies Depression Scale (CES-D). J Psychosom Res 46:437–443CrossRef Hann D, Winter K, Jacobsen P (1999) Measurement of depressive symptoms in cancer patients: evaluation of the Center for Epidemiological Studies Depression Scale (CES-D). J Psychosom Res 46:437–443CrossRef
20.
Zurück zum Zitat Hanley JA, McNeil BJ (1982) The meaning and use of the area under a receiver operating characteristic (ROC) curve. Radiology. 143:29–36CrossRef Hanley JA, McNeil BJ (1982) The meaning and use of the area under a receiver operating characteristic (ROC) curve. Radiology. 143:29–36CrossRef
21.
Zurück zum Zitat Metz CE (1978) Basic principles of ROC analysis. Semin Nucl Med 8:283–298CrossRef Metz CE (1978) Basic principles of ROC analysis. Semin Nucl Med 8:283–298CrossRef
22.
Zurück zum Zitat Rodgers J, Martin C, Morse R et al (2005) An investigation into the psychometric properties of the Hospital Anxiety and Depression Scale in patients with breast cancer. Health Qual Life Outcomes 3:41CrossRef Rodgers J, Martin C, Morse R et al (2005) An investigation into the psychometric properties of the Hospital Anxiety and Depression Scale in patients with breast cancer. Health Qual Life Outcomes 3:41CrossRef
23.
Zurück zum Zitat Cosco TD, Doyle F, Ward M, McGee H (2012) Latent structure of the Hospital Anxiety And Depression Scale: a 10-year systematic review. J Psychosom Res 72:180–184CrossRef Cosco TD, Doyle F, Ward M, McGee H (2012) Latent structure of the Hospital Anxiety And Depression Scale: a 10-year systematic review. J Psychosom Res 72:180–184CrossRef
24.
Zurück zum Zitat Norton S, Cosco T, Doyle F, Done J, Sacker A (2013) The Hospital Anxiety and Depression Scale: a meta confirmatory factor analysis. J Psychosom Res 74:74–81CrossRef Norton S, Cosco T, Doyle F, Done J, Sacker A (2013) The Hospital Anxiety and Depression Scale: a meta confirmatory factor analysis. J Psychosom Res 74:74–81CrossRef
25.
Zurück zum Zitat Straat JH, van der Ark LA, Sijtsma K (2013) Methodological artifacts in dimensionality assessment of the Hospital Anxiety and Depression Scale (HADS). J Psychosom Res 74:116–121CrossRef Straat JH, van der Ark LA, Sijtsma K (2013) Methodological artifacts in dimensionality assessment of the Hospital Anxiety and Depression Scale (HADS). J Psychosom Res 74:116–121CrossRef
26.
Zurück zum Zitat Maters GA, Sanderman R, Kim AY, Coyne JC (2013) Problems in cross-cultural use of the Hospital Anxiety and Depression Scale: “no butterflies in the desert”. PLoS One 8:e70975CrossRef Maters GA, Sanderman R, Kim AY, Coyne JC (2013) Problems in cross-cultural use of the Hospital Anxiety and Depression Scale: “no butterflies in the desert”. PLoS One 8:e70975CrossRef
27.
Zurück zum Zitat Cameron IM, Scott NW, Adler M, Reid IC (2014) A comparison of three methods of assessing differential item functioning (DIF) in the Hospital Anxiety Depression Scale: ordinal logistic regression, Rasch analysis and the Mantel chi square procedure. Qual Life Res 23:2883–2888CrossRef Cameron IM, Scott NW, Adler M, Reid IC (2014) A comparison of three methods of assessing differential item functioning (DIF) in the Hospital Anxiety Depression Scale: ordinal logistic regression, Rasch analysis and the Mantel chi square procedure. Qual Life Res 23:2883–2888CrossRef
28.
Zurück zum Zitat Verdam MG, Oort FJ, Sprangers MA (2017) Item bias detection in the Hospital Anxiety and Depression Scale using structural equation modeling: comparison with other item bias detection methods. Qual Life Res 26:1439–1450CrossRef Verdam MG, Oort FJ, Sprangers MA (2017) Item bias detection in the Hospital Anxiety and Depression Scale using structural equation modeling: comparison with other item bias detection methods. Qual Life Res 26:1439–1450CrossRef
29.
Zurück zum Zitat Saboonchi S, Wennman-Larsen A, Alexanderson K, Petersson ML (2013) Examination of the construct validity of the Swedish version of Hospital Anxiety and Depression Scale in breast cancer patients. Qual Life Res 22:2849–2856CrossRef Saboonchi S, Wennman-Larsen A, Alexanderson K, Petersson ML (2013) Examination of the construct validity of the Swedish version of Hospital Anxiety and Depression Scale in breast cancer patients. Qual Life Res 22:2849–2856CrossRef
Metadaten
Titel
Hospital Anxiety and Depression Scale (HADS) accuracy in cancer patients
verfasst von
Maria Antonietta Annunziata
Barbara Muzzatti
Ettore Bidoli
Cristiana Flaiban
Francesca Bomben
Marika Piccinin
Katiuscia Maria Gipponi
Giulia Mariutti
Sara Busato
Sara Mella
Publikationsdatum
19.12.2019
Verlag
Springer Berlin Heidelberg
Erschienen in
Supportive Care in Cancer / Ausgabe 8/2020
Print ISSN: 0941-4355
Elektronische ISSN: 1433-7339
DOI
https://doi.org/10.1007/s00520-019-05244-8

Weitere Artikel der Ausgabe 8/2020

Supportive Care in Cancer 8/2020 Zur Ausgabe

„Überwältigende“ Evidenz für Tripeltherapie beim metastasierten Prostata-Ca.

22.05.2024 Prostatakarzinom Nachrichten

Patienten mit metastasiertem hormonsensitivem Prostatakarzinom sollten nicht mehr mit einer alleinigen Androgendeprivationstherapie (ADT) behandelt werden, mahnt ein US-Team nach Sichtung der aktuellen Datenlage. Mit einer Tripeltherapie haben die Betroffenen offenbar die besten Überlebenschancen.

So sicher sind Tattoos: Neue Daten zur Risikobewertung

22.05.2024 Melanom Nachrichten

Das größte medizinische Problem bei Tattoos bleiben allergische Reaktionen. Melanome werden dadurch offensichtlich nicht gefördert, die Farbpigmente könnten aber andere Tumoren begünstigen.

CAR-M-Zellen: Warten auf das große Fressen

22.05.2024 Onkologische Immuntherapie Nachrichten

Auch myeloide Immunzellen lassen sich mit chimären Antigenrezeptoren gegen Tumoren ausstatten. Solche CAR-Fresszell-Therapien werden jetzt für solide Tumoren entwickelt. Künftig soll dieser Prozess nicht mehr ex vivo, sondern per mRNA im Körper der Betroffenen erfolgen.

Blutdrucksenkung könnte Uterusmyome verhindern

Frauen mit unbehandelter oder neu auftretender Hypertonie haben ein deutlich erhöhtes Risiko für Uterusmyome. Eine Therapie mit Antihypertensiva geht hingegen mit einer verringerten Inzidenz der gutartigen Tumoren einher.

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.